White House adviser says J&J pause to have little impact on U.S. vaccination plan

White House COVID-19 response coordinator Jeff Zients said a recommended pause in the use of the Johnson & Johnson's coronavirus vaccine will not have a significant impact on the country's vaccination plan and was taken out of "an abundance of caution."

"This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date," Zients said in a statement.